Loading
Life sciences · Interventional Study
ClinicalTrials.gov · September 25, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07841483). This is a study registration, not published results. Lead sponsor: Slingshot AI. Recruitment status: ACTIVE_NOT_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 500 participants (ESTIMATED). Conditions: Depressive Disorder, Depressive Symptoms. Interventions: BEHAVIORAL: Ash; BEHAVIORAL: Brief Therapist-Delivered Telehealth. Primary outcome measures: Change in Depressive Symptoms (PHQ-9) , Baseline (Week 0) and Week 6. Brief summary: The goal of this clinical trial is to learn if Ash, an AI chat tool for mental health, works better than static psychoedcuation in reducing mental health symptoms. Participants must be new users to the Ash app and have at least moderate symptoms of depression. The main questions it aims to answer are: * Does using Ash for 4 weeks lower depression symptoms more than 4 weeks of regularly presented psychoeducation? * Does using Ash change anxiety, sleep, stress, and other symptoms more than psychoeducation? Researchers will compare two groups to see if Ash works as well as therapy: * One group will get free access to Ash right away. * The other group will get 4 weeks of regularly presented psychoeducation, then get free access to Ash afterward. Participants will: * Fill out an online survey about their symptoms at the start of the study * Use Ash or receive psychoeducation, depending on their group * Fill out follow-up surveys about their symptoms and well-being at 2, 4, 8, and 36 weeks * Complete all study activities online; no in-person visits are required